Viome Life Sciences raises $54M for expanded clinical trials

The clinical trial results will be used to expand Viome ’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.
Source: mobihealthnews - Category: Information Technology Source Type: news